Pharmacy

A new California law will require pharmacist-led medication reviews for high-risk hospital patients at discharge starting Jan. 1, according to a Cedars-Sinai news release. The law, promoted by Cedars-Sinai, aims to prevent harmful medication errors when patients leave the hospital,…

The pharmacy benefits landscape is changing quickly, prompting health systems to adapt. With rising drug costs, regulations, and increasing demands for transparency, many are rethinking their reliance on legacy PBM contracts and are exploring modular, tech-enabled models that provide greater…

The Cigna Group’s Evernorth division introduced a rebate-free pharmacy benefit model that it says will lower medication costs and simplify drug pricing. The model removes the traditional post-purchase rebate structure by applying negotiated drug discounts upfront, according to an Oct. 27…

If you undergo a surgical procedure or are admitted to a hospital for nearly any serious condition, you are likely to receive various generic injectable drugs. From blood thinners to antibiotics to anesthetics, these essential medicines are used every day…

Health systems across the country are rethinking what pharmacy leadership looks like. The most sought-after roles today go beyond dispensing medications; they center on finance, data analytics, payer relations and technology integration, reflecting pharmacy’s growing role in both clinical and…

The FDA has reapproved GlaxoSmithKline’s belantamab mafodotin-blmf as of Oct. 23 for adults with relapsed or refractory multiple myeloma — three years after the drug was voluntarily withdrawn from the market due to unsuccessful trial results. The B-cell maturation antigen-directed…

Nearly 75% of active drug shortages in the U.S. began in 2022 or earlier, with some persisting for more than five years. According to a report from the American Society of Health-System Pharmacists released in September, the number of active…

GLP-1 prescribing in the US may have reached a plateau, new data suggests.  Prescribing rates remained stable from June to September, according to an analysis of EHR data from researchers at Truveta — a platform that includes de-identified patient data…

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an Oct. 23 statement issued ahead of a hearing before the Senate…

Becker’s asked pharmacy executives from hospitals and health systems across the U.S. to share where they see hospital consolidation going within the next five years. The 14 executives featured in this article are all speaking at the Becker’s Healthcare Spring…